Search results
Novavax Stock Doubles on $1.2B Sanofi Deal for COVID-19, Flu Vaccines
Investopedia· 19 hours agoSanofi agreed to pay Novavax $500 million upfront, with another $700 million in possible payments...
AstraZeneca Withdraws Covid-19 Vaccine, Citing Lack of Demand
Bloomberg· 3 days agoAstraZeneca Plc pulled its Covid-19 vaccine from the market due to lack of demand for a shot that...
Novavax, Sanofi Ink Deal to Commercialize COVID-19 Vaccine to Jointly Produce Combination Shots -...
EconoTimes· 17 hours agoNovavax, Inc., a biotechnology company headquartered in Gaithersburg, Maryland, revealed on Friday,...
Wednesday's Health Report: Astrazeneca pulling COVID-19 vaccine, cites low demand
WBRZ 2 Baton Rouge· 13 hours agoBATON ROUGE — U.K.-based drug manufacturer Astrazeneca is pulling its COVID-19 vaccine globally. They cited low demand. The company said ...
French, US drug firms team up for Covid-flu shot
Digital Journal· 8 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialise Novavax’s Covid-19 vaccine worldwide, except in ...
Doctor Who Falsely Claimed COVID Vaccines Make You Magnetic Has Medical License Restored
IFLScience· 14 hours agoAfter losing her medical license following a series of false claims about COVID-19 vaccines –...
AstraZeneca withdraws Covid-19 vaccine citing low demand
WKOW 27 Madison· 3 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca withdraws COVID-19 vaccine from worldwide circulation
The Washington Times· 3 days agoAstraZeneca is withdrawing its COVID-19 vaccine from worldwide circulation and marketing...
AstraZeneca withdraws Covid-19 vaccine, citing low demand - Boston News, Weather, Sports | WHDH...
7 News Boston· 2 days agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
AstraZeneca pulls its COVID-19 vaccine from the European market
San Francisco Chronicle· 2 days agoThe pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine...